Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Co-Diagnostics Inc 2401 S. FOOTHILL DRIVE SUITE D SALT LAKE CITY UT 84109 USA

www.codiagnostics.com Employees: 115 P: 801-438-1036

Sector:

Medical

Description:

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.

Key Statistics

Overview:

Market Capitalization, $K 6,016
Enterprise Value, $K -5,864
Shares Outstanding, K 3,602
Float, K 3,408
% Float 94.60%
Short Interest, K 169
Short Float 4.68%
Days to Cover 1.00
Short Volume Ratio 0.53
% of Insider Shareholders 5.40%
% of Institutional Shareholders 14.99%

Financials:

Annual Sales, $ 620 K
Annual Net Income, $ -46,900 K
Last Quarter Sales, $ 260 K
Last Quarter Net Income, $ -25,750 K
EBIT, $ -30,180 K
EBITDA, $ -29,070 K

Growth:

1-Year Return -84.61%
3-Year Return -96.04%
5-Year Return -99.38%
5-Year Revenue Growth -99.17%
5-Year Earnings Growth -146.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.80 on 11/13/25
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -18.92
EPS Growth vs. Prev Qtr 30.43%
EPS Growth vs. Prev Year 50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 01/02/26

CODX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -125.46%
Return-on-Assets % -109.63%
Profit Margin % -7,564.52%
Debt/Equity 0.00
Price/Sales 9.02
Price/Cash Flow N/A
Price/Book 0.17
Book Value/Share 9.13
Interest Coverage -0.60
60-Month Beta 1.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.